<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87162">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01669551</url>
  </required_header>
  <id_info>
    <org_study_id>UPenn 815656</org_study_id>
    <nct_id>NCT01669551</nct_id>
  </id_info>
  <brief_title>A PHASE 1 FEASIBILITY STUDY OF VOLUME INTRACARDIAC ECHO IN ASSESSMENT OF PATIENTS WITH STRUCTURAL AND VALVULAR HEART DISEASE UNDERGOING PERCUTANEOUS TRANSCATHETER THERAPY</brief_title>
  <official_title>A PHASE 1 FEASIBILITY STUDY OF VOLUME INTRACARDIAC ECHO IN ASSESSMENT OF PATIENTS WITH STRUCTURAL AND VALVULAR HEART DISEASE UNDERGOING PERCUTANEOUS TRANSCATHETER THERAPY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare 3 dimensional intracardiac echo (ICE) with 2 dimensional ICE or
      transesophageal echo in patients with structural and valvular heart disease who are already
      scheduled to undergo a percutaneous intervention. Specifically those patients would be those
      scheduled for a PFO or ASD repair, mitral balloon valvuloplasty, diagnostic cardiac
      catheterization assessment of aortic stenosis and those undergoing transcatheter aortic
      valve replacement.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Structural and Valvular Heart Disease</condition>
  <arm_group>
    <arm_group_label>Structural or Valvular Heart Disease</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with structural or valvular heart disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients in the study population referred to the cardiac catheterization laboratory
             for a percutaneous procedure to treat structural or valvular heart disease

        Exclusion Criteria:

          -  Class IV CHF, inadequate femoral access, coagulation abnormalities, intracariac
             thrombus or DVT
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Herrmann, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 16, 2012</lastchanged_date>
  <firstreceived_date>August 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
